Cargando…
SABAs as Reliever Medications in Asthma Management: Evidence-Based Science
The role of as-needed inhaled short-acting β(2)-agonists (SABAs) in the management of asthma has become a subject of debate due to differing opinions in the professional community relating to the use of SABAs. In this article, we summarize the current position of SABAs when used as reliever medicati...
Autores principales: | Amirav, Israel, Garcia, Gabriel, Le, Bao Khac, Barria, Paulina, Levy, Gur, Aggarwal, Bhumika, Fahrbach, Kyle, Martin, Amber, Phansalkar, Abhay, Sriprasart, Thitiwat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244083/ https://www.ncbi.nlm.nih.gov/pubmed/37280414 http://dx.doi.org/10.1007/s12325-023-02543-9 |
Ejemplares similares
-
Safety of SABA Monotherapy in Asthma Management: a Systematic Review and Meta-analysis
por: Sriprasart, Thitiwat, et al.
Publicado: (2022) -
Asthma and COVID-19: In Defense of Evidence-Based SABA
por: Amirav, Israel, et al.
Publicado: (2020) -
Asthma-related hospitalizations after implementing SABA-free asthma management with a maintenance and anti-inflammatory reliever regimen
por: Nannini, L. J., et al.
Publicado: (2022) -
Asthma control with ICS-formoterol reliever versus maintenance ICS and SABA reliever therapy: a post hoc analysis of two randomised controlled trials
por: Hatter, Lee, et al.
Publicado: (2022) -
Successful prone positioning after recent caesarean section in severe ARDS with postpartum pulmonary haemorrhage
por: Phoophiboon, Vorakamol, et al.
Publicado: (2020)